FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ajanta Pharma Buyback 2024 and KDDL Buyback 2024.
Ajanta Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while KDDL Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Ajanta Pharma Limited | KDDL Ltd | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ![]() |
![]() |
|||||||||
Type of Buyback | Tender Offer | Tender Offer | |||||||||
Listing At | BSE, NSE | BSE, NSE | |||||||||
Face Value | ₹2 per share | ₹10 per share | |||||||||
Buyback Price | ₹2770 per share | ₹3700 per share | |||||||||
Issue Size | 10,28,881 shares | 2,37,837 shares | |||||||||
Issue Size (Amount) | ₹285.00 Crores | ₹88.00 Crores | |||||||||
Buyback Ratio |
|
||||||||||
Registrar | Link Intime India Private Ltd | ||||||||||
Lead Managers | Vivro Financial Services Private Limited | ||||||||||
Necessity of the buyback | Buyback is being undertaken, inter-alia, for the following reasons:
|
Ajanta Pharma Buyback 2024 and KDDL Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2024 Buyback record date is May 30, 2024. KDDL Buyback 2024 Buyback record date is .
Ajanta Pharma Limited | KDDL Ltd | |
---|---|---|
Record Date | May 30, 2024 | |
Offer Open Date | Jun 05, 2024 | |
Offer Closure Date | Jun 11, 2024 | |
Last date for receipt of tender forms | Jun 11, 2024 | |
Finalisation of buyback | Jun 18, 2024 | |
Last Date for settlment of bids | Jun 19, 2024 | |
Last Date for extinguishment of shares | Jun 28, 2024 |
Comparison of Ajanta Pharma Buyback 2024 and KDDL Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Ajanta Pharma Limited | KDDL Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ajanta Pharma Limited Financial Information (Restated Consolidated)Ajanta Pharma Limited's revenue increased by 11.77% and profit after tax (PAT) rose by 38.81% between the financial year ending with March 31, 2024 and March 31, 2023.
|
KDDL Ltd Financial Information (Restated Consolidated)KDDL Ltd's revenue increased by 36.94% and profit after tax (PAT) rose by 106.94% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|